In general, apparent passenger mutations in DICER1 were enriched in hypermutated cases (mostly colorectal and esophageal cancers, and POLE subclass of endometrial cancers) in both TCGA and IMPACT cohorts (Fig. 2 and Supplementary Data 1 and 2). This evidence concerns the gene DICER1 and endometrial cancer.